CN110639018A - 一种防治老年性高血压的药物组合物及其用途 - Google Patents
一种防治老年性高血压的药物组合物及其用途 Download PDFInfo
- Publication number
- CN110639018A CN110639018A CN201911111269.6A CN201911111269A CN110639018A CN 110639018 A CN110639018 A CN 110639018A CN 201911111269 A CN201911111269 A CN 201911111269A CN 110639018 A CN110639018 A CN 110639018A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- trifluoromethyl
- phenyl
- hypertension
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911111269.6A CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911111269.6A CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110639018A true CN110639018A (zh) | 2020-01-03 |
CN110639018B CN110639018B (zh) | 2020-06-26 |
Family
ID=68995882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911111269.6A Active CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110639018B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005100298A1 (en) * | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Cetp inhibitors |
WO2010039474A1 (en) * | 2008-10-01 | 2010-04-08 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone cetp inhibitors |
WO2011058975A1 (ja) * | 2009-11-11 | 2011-05-19 | 国立大学法人富山大学 | 食後過血糖改善剤、およびピロリジン型イミノ糖またはその塩 |
WO2013063217A1 (en) * | 2011-10-28 | 2013-05-02 | Merck Sharp & Dohme Corp. | Fused bicyclic oxazolidinone cetp inhibitor |
-
2019
- 2019-11-14 CN CN201911111269.6A patent/CN110639018B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005100298A1 (en) * | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Cetp inhibitors |
WO2010039474A1 (en) * | 2008-10-01 | 2010-04-08 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone cetp inhibitors |
WO2011058975A1 (ja) * | 2009-11-11 | 2011-05-19 | 国立大学法人富山大学 | 食後過血糖改善剤、およびピロリジン型イミノ糖またはその塩 |
WO2013063217A1 (en) * | 2011-10-28 | 2013-05-02 | Merck Sharp & Dohme Corp. | Fused bicyclic oxazolidinone cetp inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN110639018B (zh) | 2020-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW389696B (en) | Accelerated release composition containing bromocriptine | |
JP2004517148A (ja) | 心機能不全および心不全の治療における必須n−3脂肪酸 | |
EA004312B1 (ru) | Применение эйкозапентаеновой и/или докозагексаеновой жирных кислот и/или их этиловых эфиров для приготовления лекарственного средства для снижения уровня смертности пациентов, перенесших инфаркт миокарда | |
JP2006506378A5 (zh) | ||
JP6792269B2 (ja) | 夜間胃酸過分泌に対するベンズイミダゾール誘導体の使用 | |
RU2001133455A (ru) | Включающие циклоспорин композиции, практически не содержащие масла | |
JP2008540405A5 (zh) | ||
JP2011190199A (ja) | 関節リウマチ薬 | |
RU2494736C2 (ru) | Комбинация, включающая паклитаксел, для лечения рака яичников | |
JP2020522560A5 (zh) | ||
US20230071766A1 (en) | Sigma-1 receptor agonist systolic blood pressure therapy | |
JP2022133449A (ja) | レボドパ分割用量組成物および使用 | |
JP5296968B2 (ja) | イブプロフェン含有経口用医薬組成物 | |
CN110639018B (zh) | 一种防治老年性高血压的药物组合物及其用途 | |
JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤 | |
US20050256131A1 (en) | Pharmaceutical active substance combination and the use thereof | |
JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
Erken | Amlodipine and gingival hyperplasia; case report with review of the literature | |
CA3164676A1 (en) | Drug for preventing dialysis shift or renal death | |
JP2007513991A (ja) | メタボリック症候群の処置のためのスタチンの使用 | |
CN102283831B (zh) | 一种治疗冠心病的西药复方及用途 | |
JP3851668B2 (ja) | 医薬用組成物 | |
ZA200607385B (en) | Pharmaceutical composition of (+)-erythro-mefloquine and its use | |
HU212941B (en) | Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril | |
JPWO2020176432A5 (zh) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhou Shufen Inventor after: Mao Yichun Inventor after: Yuan Chunhua Inventor after: Xiao Hanyan Inventor after: Wang Xiaonan Inventor after: Guo Ling Inventor before: Zhou Shufen Inventor before: Mao Yichun Inventor before: Yuan Chunhua Inventor before: Xiao Hanyan Inventor before: Wang Xiaonan |
|
CB03 | Change of inventor or designer information |